TLSI Q2 2024 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7M+59.7% YoY

Gross Profit

$6M87.6% margin

Operating Income

-$8M-111.0% margin

Net Income

-$4M-58.8% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

+14.0%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$32M

Total Liabilities

$57M

Stockholders' Equity

-$24M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$5M	+59.7%
Gross Profit	$6M	$4M	+68.0%
Operating Income	-$8M	-$11M	+28.5%
Net Income	-$4M	-$14M	+69.0%